Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Malignant Solid Neoplasm × pamiparib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 1 Solid Tumor 1 Glioma 1 Glioblastoma 1 For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment 1 Advanced Malignant Solid Neoplasm 1

Interventions

veliparib 1 pamiparib 1 dinaciclib 1 cabozantinib 1 Pharmacogenomic Variants 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05038839 2025-11-20

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Active not recruiting

Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡